Stock listing
Formosa Pharmaceuticals, Inc.
Selected listing: 6838 · TWSE · TWD · TW
Formosa Pharmaceuticals, Inc. (TWSE:6838), Health Technology. Latest release Aug 28, 2026: Formosa Pharmaceuticals Files Clinical Trial Application…
- Ticker
- TWSE:6838
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc. is a public company traded under the ticker 6838 on the Taiwan market. Formosa Pharmaceuticals focuses on developing innovative pharmaceutical solutions.
Latest news from Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers
August 28, 2026
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
May 21, 2026
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
April 30, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
February 23, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
January 12, 2026
Research Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc. company profile
View the public company page for Formosa Pharmaceuticals, Inc. on 6ix.
Formosa Pharmaceuticals, Inc. news
Read company news and market updates connected to Formosa Pharmaceuticals, Inc..
Formosa Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Formosa Pharmaceuticals, Inc..